Birmingham, West Midlands -- (SBWIRE) -- 10/21/2013 -- Value Penny Stocks issues special report on Inovio Pharmaceuticals Inc (NYSEMKT:INO), Nabors Industries Ltd. (NYSE:NBR), United Rentals, Inc. (NYSE:URI), Prospect Capital Corporation (NASDAQ:PSEC).
Inovio Pharmaceuticals Inc (NYSEMKT:INO) opened its last trade at the price of $2.11. Its closing price was $2.09 after losing -1.88% for the day. The company traded with the total volume of 3,269,818 shares, while its average trading volume remained 7.71 million shares. The beta of this stock stands at 3.32. Inovio Pharmaceuticals, Inc., together with its subsidiaries, engages in the discovery and development of synthetic vaccines and immune therapies focusing on cancers and infectious diseases.
Has INO Found The Bottom and Ready To Move Up? Find Out Here
Nabors Industries Ltd. (NYSE:NBR) percentage change surged 1.77% to close at $17.80 with the total traded volume of 3,263,460 shares, along with average volume of 3.46 million shares. The 52 week range of the stock remained $12.75 - $18.24, while its day lowest price was $17.67. The share price hit the day highest price of $17.92. Nabors Industries Ltd., together with its subsidiaries, operates as a land drilling contractor in the United States, Canada, and internationally. The company markets approximately 474 land drilling rigs for oil and gas land drilling operations in the United States Lower 48 states, Alaska, Canada.
For How Long NBR’s Gloss will Attract Investors? Find out via this report
United Rentals, Inc. (NYSE:URI) traded on volume of 3,236,196 million shares in the last session against average volume of 2.11 million shares. The company started its trading session with the price of $62.98 and closed at $64.89 by scoring +4.76%. United Rentals, Inc., through its subsidiaries, operates as an equipment rental company. It offers approximately 3,300 classes of equipment for rent to customers comprising construction and industrial companies, manufacturers, utilities, municipalities, homeowners, and government entities.
Will URI Continue To Move Higher? Find Out Here
Prospect Capital Corporation (NASDAQ:PSEC) started its last trading session with the price of $11.29 and closed at $11.31 by scoring +0.53%. The stock traded with total volume of 3,228,706 shares, while the average trading volume remained 3.13 million shares. The beta value of this stock stands at 0.89. Day range for the stock was $11.21 - $11.31. Prospect Capital Corporation is a business development company. It specializes in middle market, mature, mezzanine finance, later stage, emerging growth, buyouts, recapitalizations, turnaround, growth capital, development, cash flow term loans, and bridge transactions.
Why Should Investors Buy PSEC After The Recent Gain? Just Go Here and Find Out
About Value Penny Stocks:
Value Penny Stocks was made by Two Active traders, Steve and Wilson, whom have made a platform for traders in order to provide traders the #1 Penny Stock Newsletter which actually gives value to your money and makes your portfolio full of profits. We concentrate on small cap stocks that trade on NYSE, NASD, AMEX, OTCBB, and OTC exchanges. These are usually stocks that will trade under $5 a share and offer the utmost potential profit on your short or long term investment. We also devote ourselves to understanding the overall market situations and use this knowledge in order to gain a better perception during our stock picking decisions.
We at ValuePennyStocks.com are engaged in the business of marketing and advertising companies. All content on our website is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a solicitation of the purchase or sale of any securities.
Please Read Our Full Disclaimer at: http://www.valuepennystocks.com/disclaimer/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)